Haoxi Health Technology Limited: 2024 AGM Notice & Insights in Form 6-K Report

Here are the key insights extracted from the provided financial report (Form 6-K) for Haoxi Health Technology Limited:

1. Company Information:

• Name: Haoxi Health Technology Limited
• Address: Room 801, Tower C, Floor 8, Building 103, Huizhongli, Chaoyang District, Beijing, China.
• Contact: +86-10-13311587976

2. Report Type:

• This is a Form 6-K report filed by a foreign private issuer under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.

3. Filing Date:

• The report is dated December 19, 2024.

4. Annual General Meeting (AGM):

• The report contains a notice regarding the upcoming Annual General Meeting of Shareholders, referred to as the "Notice."
• There are proxy materials attached as Exhibit 99.2 which shareholders can use.

5. Document Availability:

• The Notice and documents can be accessed on the SEC’s website (www.sec.gov) as well as on the Company’s website (http://www.haoximedia.com/).
• Shareholders are encouraged to review the Notice for important information regarding the Company and the AGM.

6. Participants in the Solicitation:

• The Company’s directors and executive officers may be considered participants in the proxy solicitation related to the AGM. Further details about their interests are provided in the Notice.

7. Regulatory Note:

• The Notice is not subject to review by the SEC as it is filed by a foreign private issuer.

8. Signature:

• The report is signed by Zhen Fan, who is the Chief Executive Officer of Haoxi Health Technology Limited.

Overall, this filing primarily serves to inform shareholders about the upcoming Annual General Meeting, the materials available for their review, and provides necessary contact and regulatory information.